Jun Zou

568 total citations
15 papers, 393 citations indexed

About

Jun Zou is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jun Zou has authored 15 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jun Zou's work include Epigenetics and DNA Methylation (6 papers), Signaling Pathways in Disease (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Jun Zou is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Signaling Pathways in Disease (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Jun Zou collaborates with scholars based in China, United States and Japan. Jun Zou's co-authors include Yan Yang, Xingren Liu, Yang Yang, Zhaodong Han, Weide Zhong, Yuxiang Liang, Lu Guo, Yang� Yang, Jiang Huang and Huichan He and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Biomedicine & Pharmacotherapy.

In The Last Decade

Jun Zou

15 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jun Zou China	9	301	159	84	54	54	15	393
Yingfeng Zhu China	10	338 1.1×	200 1.3×	74 0.9×	36 0.7×	40 0.7×	17	459
Xianxiong Ma China	12	259 0.9×	133 0.8×	75 0.9×	65 1.2×	77 1.4×	26	394
Nanhong Tang China	11	211 0.7×	173 1.1×	102 1.2×	40 0.7×	80 1.5×	18	391
Xiaobo Yu China	11	317 1.1×	229 1.4×	97 1.2×	58 1.1×	43 0.8×	14	472
Ruijie Liu China	10	340 1.1×	126 0.8×	74 0.9×	39 0.7×	52 1.0×	17	461
Wen‐Lian Chen China	10	262 0.9×	186 1.2×	74 0.9×	50 0.9×	34 0.6×	20	419
Linfei Hu China	13	268 0.9×	119 0.7×	104 1.2×	68 1.3×	43 0.8×	34	451
Yunfei Yan China	11	289 1.0×	178 1.1×	53 0.6×	44 0.8×	39 0.7×	27	384
Pengzhou Kong China	13	257 0.9×	105 0.7×	95 1.1×	45 0.8×	42 0.8×	29	360
Jialin Feng China	12	310 1.0×	230 1.4×	55 0.7×	42 0.8×	32 0.6×	22	430

Countries citing papers authored by Jun Zou

Since Specialization

Citations

This map shows the geographic impact of Jun Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Zou more than expected).

Fields of papers citing papers by Jun Zou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Zou. The network helps show where Jun Zou may publish in the future.

Co-authorship network of co-authors of Jun Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Zou. A scholar is included among the top collaborators of Jun Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Zou. Jun Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

He, Tao, et al.. (2024). Serine/threonine kinase 36 induced epithelial-mesenchymal transition promotes docetaxel resistance in prostate cancer. Scientific Reports. 14(1). 729–729. 3 indexed citations

Mo, Rujun, et al.. (2023). Identification and Validation of FGF-Related Prognostic Signatures in Prostate Cancer. Disease Markers. 2023. 1–15. 2 indexed citations

Zou, Jun, Yanfei Chen, Xiaoping Huang, et al.. (2021). Dihydropyrimidinase Like 2 Promotes Bladder Cancer Progression via Pyruvate Kinase M2-Induced Aerobic Glycolysis and Epithelial–Mesenchymal Transition. Frontiers in Cell and Developmental Biology. 9. 13 indexed citations

Zou, Jun, Yanfei Chen, Xiaoping Huang, et al.. (2020). Dihydropyrimidinase Like 2 Promotes Bladder Cancer Progression via Pyruvate Kinase M2-Induced Aerobic Glycolysis and Epithelial–Mesenchymal Transition. SSRN Electronic Journal. 1 indexed citations

Zou, Jun, Huajun Li, Bin Wang, et al.. (2019). <p>Secreted TGF-beta-induced protein promotes aggressive progression in bladder cancer cells</p>. Cancer Management and Research. Volume 11. 6995–7006. 34 indexed citations

Zou, Jun, Yan Yang, Yang Yang, & Xingren Liu. (2018). Polydatin suppresses proliferation and metastasis of non-small cell lung cancer cells by inhibiting NLRP3 inflammasome activation via NF-κB pathway. Biomedicine & Pharmacotherapy. 108. 130–136. 76 indexed citations

Yang, Yan, Yang� Yang, Lu Guo, et al.. (2018). Silencing of LncRNA-HOTAIR decreases drug resistance of Non-Small Cell Lung Cancer cells by inactivating autophagy via suppressing the phosphorylation of ULK1. Biochemical and Biophysical Research Communications. 497(4). 1003–1010. 91 indexed citations

Zou, Jun, Funeng Jiang, Dexiong Chen, et al.. (2018). Overexpression of TPX2 is associated with progression and prognosis of prostate cancer. Oncology Letters. 16(3). 2823–2832. 31 indexed citations

Zhang, Ting, Guiwen Guan, Tingting Chen, et al.. (2018). Methylation of PCDH19 predicts poor prognosis of hepatocellular carcinoma. Asia-Pacific Journal of Clinical Oncology. 14(5). e352–e358. 21 indexed citations

10.

Liang, Yuxiang, Rujun Mo, Huichan He, et al.. (2015). Aberrant hypomethylation-mediated CD147 overexpression promotes aggressive tumor progression in human prostate cancer. Oncology Reports. 33(5). 2648–2654. 7 indexed citations

11.

Zou, Jun, Zhaodong Han, Liang Zhou, et al.. (2014). Elevated expression of IMPDH2 is associated with progression of kidney and bladder cancer. Medical Oncology. 32(1). 373–373. 24 indexed citations

12.

He, Huichan, Zhaodong Han, Qi-Shan Dai, et al.. (2009). [Expression and significance of CD147 protein in prostate cancer].. PubMed. 89(26). 1844–6. 3 indexed citations

13.

Han, Zhaodong, Xue‐cheng Bi, Weijun Qin, et al.. (2008). CD147 Expression Indicates Unfavourable Prognosis in Prostate Cancer. Pathology & Oncology Research. 15(3). 369–374. 38 indexed citations

14.

Han, Zhaodong, Huichan He, Xue‐cheng Bi, et al.. (2008). Expression and Clinical Significance of CD147 in Genitourinary Carcinomas. Journal of Surgical Research. 160(2). 260–267. 41 indexed citations

15.

Chu, Xiaoyu, et al.. (2007). Effect of dl-praeruptorin A on desmin and vimentin content in rat ischemia/reperfusion myocardiocytes. Chinese Medical Journal. 120(24). 2256–2259. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact